David Chung Hsia

Title: Innovations in Oral Delivery: The Contributions of David Chung Hsia

Introduction

David Chung Hsia is an accomplished inventor based in Irvine, CA, known for his significant contributions to the field of pharmaceutical sciences. With a total of two patents to his name, Hsia has focused on developing innovative dosage forms for the oral delivery of progesterone. His work aims to enhance the therapeutic efficacy of hormone therapies.

Latest Patents

Hsia's latest patents include groundbreaking formulations for oral progesterone dosage forms. One patent describes oral progesterone unit dosage forms that comprise micronized progesterone combined with a solid polymeric carrier. These dosage forms are designed to provide a therapeutically effective blood level of progesterone, ranging from about 0.1 ng/ml to about 400 ng/ml upon oral administration. The formulations can be prepared for both immediate and sustained release, offering flexibility in treatment options. Another patent focuses on a combined dosage form of progesterone and estrogen, ensuring effective hormone therapy through the gastrointestinal tract.

Career Highlights

David Chung Hsia has made notable strides in his career, particularly through his work at Watson Pharmaceuticals, Inc. His innovative approaches to drug formulation have positioned him as a key figure in the development of hormone therapies. Hsia's expertise in pharmaceutical sciences has contributed to advancements in patient care and treatment efficacy.

Collaborations

Hsia has collaborated with esteemed colleagues such as Thomas Ho and Domingo Yap Tan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

David Chung Hsia's contributions to the development of oral dosage forms for progesterone highlight his commitment to advancing pharmaceutical sciences. His innovative patents and collaborative efforts continue to impact the field positively.